Davis biotech firm Marrone Bio Innovations Inc. said Tuesday that it is offering more than 5.7 million registered shares of its common stock at a public price of $1.40 a share, which would generate about $8 million.
Marrone announced Monday that it intended to offer shares of its common stock in an underwritten public offering.
The company said it has granted the underwriter a 45-day option to purchase up to an additional 857,143 shares of common stock offered in the public offering to cover over-allotments, if any.
The offering is expected to close Friday, subject to standard conditions.
Sign Up and Save
Get six months of free digital access to The Sacramento Bee